We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHO icon
626
Invesco Water Resources ETF
PHO
$2.03B
$1.51M 0.01%
21,400
+1,600
+8% +$109K
IVE icon
627
iShares S&P 500 Value ETF
IVE
$49.1B
$1.49M 0.01%
7,544
– –
SUN icon
628
Sunoco
SUN
$14.4B
$1.48M 0.01%
27,500
+8,000
+41% +$434K
MNDY icon
629
monday.com
MNDY
$3.82B
$1.47M 0.01%
5,298
-109
-2% -$27K
CAG icon
630
Conagra Brands
CAG
$7.42B
$1.47M 0.01%
45,221
-585
-1% -$17.9K
MLI icon
631
Mueller Industries
MLI
$14.5B
$1.45M 0.01%
39,234
+3,952
+11% +$132K
WAB icon
632
Wabtec
WAB
$49.3B
$1.45M 0.01%
7,996
+1,930
+32% +$317K
NVT icon
633
nVent Electric
NVT
$21.6B
$1.45M 0.01%
20,582
-259
-1% -$17.9K
DSGX icon
634
Descartes Systems
DSGX
$6.68B
$1.43M 0.01%
13,908
+45
+0.3% +$4.47K
ATI icon
635
ATI
ATI
$24.3B
$1.41M 0.01%
21,100
+753
+4% +$46.8K
ADM icon
636
Archer Daniels Midland
ADM
$38.7B
$1.41M 0.01%
23,578
+7,558
+47% +$461K
BRSL
637
Brightstar Lottery PLC
BRSL
$1.9B
$1.41M 0.01%
66,127
+76
+0.1% +$1.63K
RPRX icon
638
Royalty Pharma
RPRX
$26.2B
$1.4M 0.01%
49,579
-198,419
-80% -$5.5M
CE icon
639
Celanese
CE
$4.82B
$1.4M 0.01%
10,296
+359
+4% +$47.2K
FLR icon
640
Fluor
FLR
$6.54B
$1.39M 0.01%
29,235
+12
+0% +$566
DVN icon
641
Devon Energy
DVN
$51.3B
$1.39M 0.01%
35,654
+19,589
+122% +$863K
SNX icon
642
TD Synnex
SNX
$19.9B
$1.38M 0.01%
11,517
-67,975
-86% -$7.86M
COLB icon
643
Columbia Banking Systems
COLB
$8.71B
$1.38M 0.01%
52,764
+7,704
+17% +$183K
AAON icon
644
Aaon
AAON
$6.95B
$1.38M 0.01%
12,753
-36
-0.3% -$3.29K
SHAK icon
645
Shake Shack
SHAK
$2.54B
$1.37M 0.01%
13,293
+199
+2% +$19.2K
VFH icon
646
Vanguard Financials ETF
VFH
$13.4B
$1.37M 0.01%
12,426
– –
JNPR
647
DELISTED
Juniper Networks
JNPR
$1.35M 0.01%
34,755
+851
+3% +$32.5K
TRMB icon
648
Trimble
TRMB
$13.6B
$1.35M 0.01%
21,722
-7,898
-27% -$441K
RMD icon
649
ResMed
RMD
$31.1B
$1.33M 0.01%
5,441
-57
-1% -$12.7K
JWN
650
DELISTED
Nordstrom
JWN
$1.32M 0.01%
58,705
+30
+0.1% +$666
24 25
26
27 28

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.